The Pennant Group (NASDAQ:PNTG) Releases FY 2026 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) issued an update on its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of 1.340-1.410 for the period, compared to the consensus estimate of 1.360. The company issued revenue guidance of $1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

The Pennant Group Trading Down 5.5%

The Pennant Group stock traded down $2.19 during trading hours on Friday, reaching $37.80. The company had a trading volume of 346,900 shares, compared to its average volume of 302,375. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.20 and a quick ratio of 1.20. The company has a 50-day moving average price of $40.19 and a 200 day moving average price of $35.66. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of 38.18, a P/E/G ratio of 2.87 and a beta of 1.33. The Pennant Group has a 12-month low of $23.50 and a 12-month high of $44.24.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.01). The Pennant Group had a net margin of 3.05% and a return on equity of 10.43%. The company had revenue of $302.25 million during the quarter, compared to the consensus estimate of $299.34 million. Equities analysts forecast that The Pennant Group will post 1.18 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Royal Bank Of Canada reissued an “outperform” rating on shares of The Pennant Group in a research report on Friday. Wells Fargo & Company raised their price target on shares of The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Truist Financial boosted their price objective on shares of The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Oppenheimer upped their price objective on shares of The Pennant Group from $47.00 to $50.00 and gave the company an “outperform” rating in a research note on Thursday. Finally, Weiss Ratings raised shares of The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Six investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, The Pennant Group presently has an average rating of “Moderate Buy” and an average price target of $47.00.

About The Pennant Group

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.